Successful pregnancy depends on the precise regulation of extravilloustrophoblast (EVT) invasion into the uterine decidua. SPARC (secreted protein acidic and rich in cysteine) is a matricellular glycoprotein that plays critical roles in the pathologies associated with obesity and diabetes, as well as tumorigenesis. The objective of this study was to investigate the role of SPARC in the process of trophoblast invasion which shares many similarities with tumor cell invasion. By Western blot, higher expression of SPARC was observed in mouse brain, ovary and uterus compared to other mouse tissues. Immunohistochemistry analysis revealed a spatio-temporal expression of SPARC in mouse uterus in the periimplantation period. At the implantation site of d8 pregnancy, SPARC mainly accumulated in the secondary decidua zone (SDZ), trophoblast cells and blastocyst. The expression of SPARC was also detected in human placental villi and trophoblast cell lines. In a Matrigel invasion assay, we found SPARC-specific RNA interference significantly reduced the invasion of human extravilloustrophoblast HTR8/SVneo cells. Microarray analysis revealed that SPARC depletion upregulated the expression of interleukin 11 (IL11), KISS1, insulin-like growth factor binding protein 4 (IGFBP4), collagen type I alpha 1 (COLIA1), matrix metallopeptidase 9 (MMP9), and downregulated the expression of the alpha polypeptide of chorionic gonadotropin (CGA), MMP1, gap junction protein alpha 1 (GJA1), et al. The gene array result was further validated by qRT-PCR and Western blot. The present data indicate that SPARC may play an important role in the regulation of normal placentation by promoting the invasion of trophoblast cells into the uterine decidua.
References
[1]
Achache H, Revel A (2006) Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 12: 731–746.
[2]
Carson DD, Bagchi I, Dey SK, Enders AC, Fazleabas AT, et al. (2000) Embryo implantation. Dev Biol 223: 217–237.
[3]
Soundararajan R, Rao AJ (2004) Trophoblast ‘pseudo-tumorigenesis’: significance and contributory factors. Reprod Biol Endocrinol 2: 15.
[4]
Warning JC, McCracken SA, Morris JM (2011) A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 141: 715–724.
[5]
Knofler M, Simmons DG, Lash GE, Harris LK, Armant DR (2008) Regulation of trophoblast invasion – a workshop report. Placenta 29 Suppl A: S26–28.
[6]
Harris LK (2011) Review: Trophoblast-vascular cell interactions in early pregnancy: how to remodel a vessel. Placenta 31 Suppl: S93–98
[7]
Staun-Ram E, Shalev E (2005) Human trophoblast function during the implantation process. Reprod Biol Endocrinol 3: 56.
[8]
Brekken RA, Sage EH (2001) SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 19: 816–827.
[9]
Yan Q, Sage EH (1999) SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem 47: 1495–1506.
[10]
Chlenski A, Cohn SL (2010) Modulation of matrix remodeling by SPARC in neoplastic progression. Semin Cell Dev Biol 21: 55–65.
[11]
Jorgensen LH, Petersson SJ, Sellathurai J, Andersen DC, Thayssen S, et al. (2009) Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle. J Histochem Cytochem 57: 29–39.
[12]
Kos K, Wilding JP (2010) SPARC: a key player in the pathologies associated with obesity and diabetes. Nat Rev Endocrinol 6: 225–235.
[13]
Hasselaar P, Sage EH (1992) SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 49: 272–283.
[14]
Arnold SA, Brekken RA (2009) SPARC: a matricellular regulator of tumorigenesis. J Cell Commun Signal 3: 255–273.
[15]
Robert G, Gaggioli C, Bailet O, Chavey C, Abbe P, et al. (2006) SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res 66: 7516–7523.
[16]
Sturm RA, Satyamoorthy K, Meier F, Gardiner BB, Smit DJ, et al. (2002) Osteonectin/SPARC induction by ectopic beta (3) integrin in human radial growth phase primary melanoma cells. Cancer Res 62: 226–232.
[17]
Rempel SA, Ge S, Gutierrez JA (1999) SPARC: a potential diagnostic marker of invasive meningiomas. Clin Cancer Res 5: 237–241.
[18]
Schittenhelm J, Mittelbronn M, Roser F, Tatagiba M, Mawrin C, et al. (2006) Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas. Neuropathol Appl Neurobiol 32: 525–531.
[19]
Dalla-Torre CA, Yoshimoto M, Lee CH, Joshua AM, de ToledoSR, et al. (2006) Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma. BMC Cancer 6: 237.
[20]
Shi Q, Bao S, Song L, Wu Q, Bigner DD, et al. (2007) Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene 26: 4084–4094.
[21]
Framson PE, Sage EH (2004) SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92: 679–690.
[22]
Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, et al. (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206: 204–211.
[23]
Qiu Q, Yang M, Tsang BK, Gruslin A (2004) EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. Reproduction 128: 355–363.
[24]
Tsukihara S, Harada T, Deura I, Mitsunari M, Yoshida S, et al. (2004) Interleukin-1beta-induced expression of IL-6 and production of human chorionic gonadotropin in human trophoblast cells via nuclear factor-kappaB activation. Am J Reprod Immunol 52: 218–223.
[25]
Xu P, Wang Y, Piao Y, Bai S, Xiao Z, et al. (2001) Effects of matrix proteins on the expression of matrix metalloproteinase-2, -9, and -14 and tissue inhibitors of metalloproteinases in human cytotrophoblast cells during the first trimester. Biol Reprod 65: 240–246.
[26]
Seno T, Harada H, Kohno S, Teraoka M, Inoue A, et al. (2009) Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas. Int J Oncol 34: 707–715.
[27]
Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D (2007) Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update 13: 121–141.
[28]
Wewer UM, Albrechtsen R, Fisher LW, Young MF, Termine JD (1988) Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane. Am J Pathol 132: 345–355.
[29]
Bornstein P (2002) Cell-matrix interactions: the view from the outside. Methods Cell Biol 69: 7–11.
[30]
Pen A, Moreno MJ, Martin J, Stanimirovic DB (2007) Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels. Glia 55: 559–572.
[31]
Podhajcer OL, Benedetti LG, Girotti MR, Prada F, Salvatierra E, et al. (2008) The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev 27: 691–705.
[32]
Brekken RA, Puolakkainen P, Graves DC, Workman G, Lubkin SR, et al. (2003) Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. J Clin Invest 111: 487–495.
[33]
Gruber HE, Sage EH, Norton HJ, Funk S, Ingram J, et al. (2005) Targeted deletion of the SPARC gene accelerates disc degeneration in the aging mouse. J Histochem Cytochem 53: 1131–1138.
[34]
Strup-Perrot C, Mathe D, Linard C, Violot D, Milliat F, et al. (2004) Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. Am J Physiol Gastrointest Liver Physiol 287: G875–885.
[35]
Arnold S, Mira E, Muneer S, Korpanty G, Beck AW, et al. (2008) Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC. Exp Biol Med (Maywood) 233: 860–873.
[36]
Bhoopathi P, Chetty C, Gujrati M, Dinh DH, Rao JS, et al. (2010) The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine. Br J Cancer 102: 530–540.
[37]
Atorrasagasti C, Peixoto E, Aquino JB, Kippes N, Malvicini M, et al. (2013) Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice. PLoS One 8: e54962.
[38]
Prast J, Saleh L, Husslein H, Sonderegger S, Helmer H, et al. (2008) Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling. Endocrinology 149: 979–987.
[39]
Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, et al. (1998) Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 4: 303–308.
[40]
White CA, Robb L, Salamonsen LA (2004) Uterine extracellular matrix components are altered during defective decidualization in interleukin-11 receptor alpha deficient mice. Reprod Biol Endocrinol 2: 76.
[41]
Nestler JE (1987) Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor I. Endocrinology. 121: 1845–1852.
[42]
Kniss DA, Shubert PJ, Zimmerman PD, Landon MB, Gabbe SG (1994) Insulinlike growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. J Reprod Med 39: 249–256.
[43]
McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK (2001) Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 86: 3665–3674.
[44]
Hwa V, Oh Y, Rosenfeld RG (1999) Insulin-like growth factor binding proteins: a proposed superfamily. Acta Paediatr Suppl 88: 37–45.
[45]
Fowlkes JL (1997) Insulinlike growth factor-binding protein proteolysis an emerging paradigm in insulinlike growth factor physiology. Trends Endocrinol Metab 8: 299–306.
[46]
Chandrasekhar S, Harvey AK, Johnson MG, Becker GW (1994) Osteonectin/SPARC is a product of articular chondrocytes/cartilage and is regulated by cytokines and growth factors. Biochim Biophys Acta 1221: 7–14.
[47]
Terao Y, Kumano S, Takatsu Y, Hattori M, Nishimura A, et al. (2004) Expression of KiSS-1, a metastasis suppressor gene, in trophoblast giant cells of the rat placenta. Biochim Biophys Acta 1678: 102–110.
[48]
Hiden U, Bilban M, Knofler M, Desoye G (2007) Kisspeptins and the placenta: regulation of trophoblast invasion. Rev Endocr Metab Disord 8: 31–39.
